Business Valuation

With regard to this listing application, AVISTA Group is honored to be engaged in providing Financial Assets, Preferred Share and Share Incentive related valuation services. <img src="../../../../../uploads/Abbisko_Eng_cover_1015_8521615a5d.png" alt="" width="800" height="613" />

93249563_l.jpg

Congratulations to Abbisko Cayman Limited (2256.HK) on its Successful Listing

With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services in relation to the employee share incentive scheme offered by Tam Jai International for financial reporting purposes.
<img src="../../../../../../../uploads/Tam_Jai_Eng_03cbe9e7f2.JPG" alt="" width="800" height="600" />

 Congratulations to Tam Jai International Co. Limited (2217.HK) on its Successful Listing

Congratulations to our client, Prenetics Group Limited, has entered into a definitive merger agreement with Artisan Acquisition Corp. (Nasdaq: ARTAU) on 16 September 2021. 
With regard to this acquisition, AVISTA Group is honored to be engaged in providing valuation services in relation to the analysis of Preferred Shares and Ordinary Shares, Convertible Bonds and Exchangeable Notes for financial reporting purpose.
<img src="../../../../../uploads/Chi_Prenetics_fcb01116ca.JPG" alt="" width="800" />

Congratulations to Prenetics Group Limited has entered into a definitive merger agreement with Artisan Acquisition Corp. (Nasdaq: ARTAU) 

AVISTA is pleased to be invited to take part in contributing knowledge on The ALB Hong Kong IPO Handbook 2021 published by Asian Legal Business. We shared the knowledge on the topic of ‘The essentiality of valuation in IPO preparation’ and ‘Risk management and internal control systems for listed companies’.
 
The chapters cover the role of valuation that is worth attention across different stages of IPO preparation, ranging from pre-IPO financing to compilation of listing documents, as well as the key steps involved in developing risk management and internal control systems prior to listing with case studies illustrating common forms of internal control deficiencies. It is now available to download the digital bilingual version <a href="https://www.legalbusinessonline.com/node/81913">online</a>.
 
<img src="../../../../../../../uploads/Box_cover_2895691ca2.png" alt="" width="622" height="844" />

banner1

As the contributor of The ALB Hong Kong IPO Handbook 2021 published by Asian Legal Business

Our Managing Director, Mr. Vincent Pang was pleased to be invited by the CFA Society Shanghai to speak on the “High-Risk, High-Reward? How to assess the value of a Biotech company?” webinar.
 
The webinar gathered fellow CFAs that would like to better understand the valuation of biotechnology company. Investors have already been placing more and more attention on the Biotech sector in recent years. However, Unlike the traditional company, the Biotech company have a high failure rate on the products they attempt to invent or the products are unable to obtain regulatory approval. Therefore, investing in biotech industry is considered as a high-risk investment.
 
Vincent introduced the attributes of biotechnology industry and shared the valuation methods for biotechnology company with case studies.
<img src="../../../../../../../uploads/Cover_page_3116160cd4.png" alt="" width="500" height="319" />
<img src="../../../../../../../uploads/PPT_4b289025da.png" alt="" width="500" height="347" />

pinwheel-1716620_1920

As the speaker of the CFA Society Shanghai webinar—"High-Risk, High-Reward? How to assess the value of a Biotech company?”

Congratulations to GalaxyCore Inc. (Stock Code: 688728.SH) on its successful listing on SHSE on 18 August 2021. With regard to this listing application, AVISTA is honored to be engaged in providing valuation services in relation to equity incentive plans.
<img src="../../../../../uploads/Galaxycore_En_4ebfded184.JPG" width="700" />
<img src="Galaxycore_En.JPG" alt="" width="700" />

 Congratulations to GalaxyCore Inc.  (Stock Code: 688728.SH) on its Successful Listing

Our Managing Director, Mr. Vincent Pang was pleased to be invited by the Hong Kong Independent Non-Executive Director Association (HKiNEDA) to co-host the webinar “Valuation Issues in times of COVID-19: What you need to know” with Ms. Shelly So, Partner, Accounting Consulting Services of PwC HK.
 
The speakers introduced the impact of COVID-19 on the business performance of companies, capital market and the operation of investment activities globally and shared insights on how should executives tackle valuation issues during the pandemic in relation to the following three aspects: impairment assessment of non-financial assets, expected credit loss of financial assets and valuation of equity investment, with reference to the related accounting standards and financial reporting standards.
 
Also, key highlights of the HKEx enquiries in 2020 were covered to emphasize the importance of sufficient and transparent disclosures on impacts caused by COVID-19.
 
<img src="../../../../../uploads/hkined_webinar_1_5190b122a1.png" width="700" />
 
<img src="../../../../../uploads/hkined_webinar_2_1a6862b408.png" width="700" />